These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 11844209
1. First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population. Brizot ML, Carvalho MH, Liao AW, Reis NS, Armbruster-Moraes E, Zugaib M. Ultrasound Obstet Gynecol; 2001 Dec; 18(6):652-5. PubMed ID: 11844209 [Abstract] [Full Text] [Related]
2. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population. Chasen ST, Sharma G, Kalish RB, Chervenak FA. Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508 [Abstract] [Full Text] [Related]
3. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia. Zoppi MA, Ibba RM, Floris M, Monni G. Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208 [Abstract] [Full Text] [Related]
4. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland. Gasiorek-Wiens A, Tercanli S, Kozlowski P, Kossakiewicz A, Minderer S, Meyberg H, Kamin G, Germer U, Bielicki M, Hackelöer BJ, Sarlay D, Kuhn P, Klapp J, Bahlmann F, Pruggmayer M, Schneider KT, Seefried W, Fritzer E, von Kaisenberg CS, German-Speaking Down Syndrome Screening Group. Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207 [Abstract] [Full Text] [Related]
5. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study. von Kaisenberg CS, Gasiorek-Wiens A, Bielicki M, Bahlmann F, Meyberg H, Kossakiewicz A, Pruggmayer M, Kamin G, Fritzer E, Harris C, Arnold N, German Speaking Down Syndrome Screening Group. J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837 [Abstract] [Full Text] [Related]
6. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. Lancet; 1998 Aug 01; 352(9125):343-6. PubMed ID: 9717920 [Abstract] [Full Text] [Related]
7. [Screening for aneuploidy by first trimester nuchal translucency measurement: results from a prospective trial including 1980 cases in a single center in Switzerland]. Tercanli S, Holzgreve W, Batukan C, Gerber A, Ermis H, Miny P. Ultraschall Med; 2002 Feb 01; 23(1):22-6. PubMed ID: 11842368 [Abstract] [Full Text] [Related]
8. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH. Ultrasound Obstet Gynecol; 2008 Apr 01; 31(4):376-83. PubMed ID: 18383462 [Abstract] [Full Text] [Related]
9. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Sebire NJ, Snijders RJ, Hughes K, Sepulveda W, Nicolaides KH. Br J Obstet Gynaecol; 1996 Oct 01; 103(10):999-1003. PubMed ID: 8863698 [Abstract] [Full Text] [Related]
11. Relationship between fetal nuchal translucency and crown-rump length in an Asian population. Jou HJ, Wu SC, Li TC, Hsu HC, Tzeng CY, Hsieh FJ. Ultrasound Obstet Gynecol; 2001 Feb 01; 17(2):111-4. PubMed ID: 11251917 [Abstract] [Full Text] [Related]
12. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population. Pajkrt E, van Lith JM, Mol BW, Bleker OP, Bilardo CM. Ultrasound Obstet Gynecol; 1998 Sep 01; 12(3):163-9. PubMed ID: 9793187 [Abstract] [Full Text] [Related]
13. Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation. Hyett JA, Noble PL, Snijders RJ, Montenegro N, Nicolaides KH. Ultrasound Obstet Gynecol; 1996 Apr 01; 7(4):239-44. PubMed ID: 8726874 [Abstract] [Full Text] [Related]
14. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation. Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH. Am J Med Genet; 1999 Sep 17; 86(3):205-7. PubMed ID: 10482866 [Abstract] [Full Text] [Related]
15. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Pandya PP, Snijders RJ, Johnson SP, De Lourdes Brizot M, Nicolaides KH. Br J Obstet Gynaecol; 1995 Dec 17; 102(12):957-62. PubMed ID: 8652486 [Abstract] [Full Text] [Related]
16. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. Ultrasound Obstet Gynecol; 1999 Apr 17; 13(4):231-7. PubMed ID: 10341399 [Abstract] [Full Text] [Related]
17. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks. Karadzov-Orlić N, Egić A, Filimonović D, Marinković M, Damnjanović-Pazin B, Milovanović Z, Joksić I, Branković S, Lukić R, Mandić V, Cerović N, Mojović D, Plamenac S, Stanković M, Maglić D, Mikovć Z. Srp Arh Celok Lek; 2012 Apr 17; 140(9-10):606-11. PubMed ID: 23289277 [Abstract] [Full Text] [Related]
18. [Increased nuchal translucency with normal karyotype]. Nicolaides KH, Wegrzyn P. Ginekol Pol; 2005 Aug 17; 76(8):593-601. PubMed ID: 16363364 [Abstract] [Full Text] [Related]
19. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age. Theodoropoulos P, Lolis D, Papageorgiou C, Papaioannou S, Plachouras N, Makrydimas G. Prenat Diagn; 1998 Feb 17; 18(2):133-7. PubMed ID: 9516014 [Abstract] [Full Text] [Related]